Literature DB >> 28695388

Measuring Acceptability and Preferences for Implementation of Pre-Exposure Prophylaxis (PrEP) Using Conjoint Analysis: An Application to Primary HIV Prevention Among High Risk Drug Users.

Roman Shrestha1,2, Pramila Karki3,4, Frederick L Altice3,5, Oleksandr Dubov6, Liana Fraenkel7, Tania Huedo-Medina3,4, Michael Copenhaver3,4.   

Abstract

Although people who use drugs (PWUD) are one of the key risk populations who could benefit from the use of pre-exposure prophylaxis (PrEP), to date, little attention has been given to incorporating PrEP into HIV prevention approaches targeting this underserved group. This study investigated the acceptability of PrEP based on a number of known PrEP attributes among high-risk PWUD in a drug treatment setting. A total of 400 HIV-negative PWUD, who reported drug- and/or sex-related risk behaviors were recruited from a methadone clinic to complete a stated preference (full-profile conjoint) survey. Participants ranked the eight hypothetical PrEP program scenarios with varied combinations of six attributes related to PrEP (cost, dosing, efficacy, side-effects, treatment setting, and frequency of HIV testing). SPSS conjoint procedure was used to estimate the relative importance of each attribute and preferences across eight possible PrEP delivery programs. PrEP acceptability ranged from 30.6 to 86.3% with a mean acceptability of 56.2% across the eight hypothetical PrEP program scenarios. The PrEP program scenario with the highest acceptability had the following attribute levels: insurance covered, daily dosing, 95% effective, no side-effects, treatment at HIV clinic, and HIV testing needed every 6 months. The cost associated with PrEP was the most important attribute (relative importance score: RIS = 38.8), followed by efficacy (RIS = 20.5) and side effects (RIS = 11.9); other attributes had no significant effect. Our findings reported a high acceptability of PrEP in response to different PrEP program scenarios with different attribute profiles. As the result of having this information, researchers and policymakers will be better equipped for evidence informed targeting and dissemination efforts to optimize PrEP uptake among this underserved population.

Entities:  

Keywords:  Conjoint analysis; HIV prevention; Implementation science; Patient preferences; People who use drugs (PWUD); Pre-exposure prophylaxis (PrEP)

Mesh:

Substances:

Year:  2018        PMID: 28695388      PMCID: PMC5762432          DOI: 10.1007/s10461-017-1851-1

Source DB:  PubMed          Journal:  AIDS Behav        ISSN: 1090-7165


  69 in total

1.  A controlled trial of methadone treatment combined with directly observed isoniazid for tuberculosis prevention in injection drug users.

Authors:  Steven L Batki; Valerie A Gruber; Julia Moon Bradley; Mark Bradley; Kevin Delucchi
Journal:  Drug Alcohol Depend       Date:  2002-05-01       Impact factor: 4.492

Review 2.  Oral substitution treatment of injecting opioid users for prevention of HIV infection.

Authors:  Linda Gowing; Michael F Farrell; Reinhard Bornemann; Lynn E Sullivan; Robert Ali
Journal:  Cochrane Database Syst Rev       Date:  2011-08-10

3.  Correlates of willingness to initiate pre-exposure prophylaxis and anticipation of practicing safer drug- and sex-related behaviors among high-risk drug users on methadone treatment.

Authors:  Roman Shrestha; Pramila Karki; Frederick L Altice; Tania B Huedo-Medina; Jaimie P Meyer; Lynn Madden; Michael Copenhaver
Journal:  Drug Alcohol Depend       Date:  2017-02-02       Impact factor: 4.492

4.  Intent to Use Preexposure Prophylaxis (PrEP), HIV Risk Behaviors, and Self-Report Neurocognitive Symptoms by High-Risk Drug Users: A Mediation Analysis.

Authors:  Roman Shrestha; Pramila Karki; Tania B Huedo-Medina; Michael Copenhaver
Journal:  J Assoc Nurses AIDS Care       Date:  2017-04-19       Impact factor: 1.354

5.  Antiretroviral preexposure prophylaxis for heterosexual HIV transmission in Botswana.

Authors:  Michael C Thigpen; Poloko M Kebaabetswe; Lynn A Paxton; Dawn K Smith; Charles E Rose; Tebogo M Segolodi; Faith L Henderson; Sonal R Pathak; Fatma A Soud; Kata L Chillag; Rodreck Mutanhaurwa; Lovemore Ian Chirwa; Michael Kasonde; Daniel Abebe; Evans Buliva; Roman J Gvetadze; Sandra Johnson; Thom Sukalac; Vasavi T Thomas; Clyde Hart; Jeffrey A Johnson; C Kevin Malotte; Craig W Hendrix; John T Brooks
Journal:  N Engl J Med       Date:  2012-07-11       Impact factor: 91.245

6.  Views of older people on cataract surgery options: an assessment of preferences by conjoint analysis.

Authors:  M-A Ross; A J Avery; A J E Foss
Journal:  Qual Saf Health Care       Date:  2003-02

7.  The Impact of Methadone Maintenance Treatment on HIV Risk Behaviors among High-Risk Injection Drug Users: A Systematic Review.

Authors:  Pramila Karki; Roman Shrestha; Tania B Huedo-Medina; Michael Copenhaver
Journal:  Evid Based Med Public Health       Date:  2016-03-22

Review 8.  The information-motivation-behavioral skills model of antiretroviral adherence and its applications.

Authors:  Jeffrey D Fisher; K Rivet Amico; William A Fisher; Jennifer J Harman
Journal:  Curr HIV/AIDS Rep       Date:  2008-11       Impact factor: 5.071

9.  Prevention and treatment produced large decreases in HIV incidence in a model of people who inject drugs.

Authors:  Brandon D L Marshall; Samuel R Friedman; João F G Monteiro; Magdalena Paczkowski; Barbara Tempalski; Enrique R Pouget; Mark N Lurie; Sandro Galea
Journal:  Health Aff (Millwood)       Date:  2014-03       Impact factor: 6.301

10.  High acceptability of HIV pre-exposure prophylaxis but challenges in adherence and use: qualitative insights from a phase I trial of intermittent and daily PrEP in at-risk populations in Kenya.

Authors:  Elisabeth Maria Van der Elst; Judie Mbogua; Don Operario; Gaudensia Mutua; Caroline Kuo; Peter Mugo; Jennifer Kanungi; Sagri Singh; Jessica Haberer; Frances Priddy; Eduard Joachim Sanders
Journal:  AIDS Behav       Date:  2013-07
View more
  20 in total

1.  Examining HIV Diagnosis and Linkage to PrEP Prescription Among Members at An Integrated Health System in the Southeast United States.

Authors:  Teaniese L Davis; Mona Mittal; Adanna C Oragwu; Min Qi Wang; Bradley O Boekeloo
Journal:  AIDS Behav       Date:  2022-09-12

Review 2.  HIV and Substance Use in Latin America: A Scoping Review.

Authors:  Hanalise V Huff; Paloma M Carcamo; Monica M Diaz; Jamie L Conklin; Justina Salvatierra; Rocio Aponte; Patricia J Garcia
Journal:  Int J Environ Res Public Health       Date:  2022-06-12       Impact factor: 4.614

Review 3.  PrEP Product Acceptability and Dual Process Decision-Making Among Men Who Have Sex with Men.

Authors:  José A Bauermeister; Julie S Downs; Douglas S Krakower
Journal:  Curr HIV/AIDS Rep       Date:  2020-06       Impact factor: 5.071

4.  Integrated Bio-behavioral Approach to Improve Adherence to Pre-exposure Prophylaxis and Reduce HIV Risk in People Who Use Drugs: A Pilot Feasibility Study.

Authors:  Roman Shrestha; Frederick L Altice; Pramila Karki; Michael M Copenhaver
Journal:  AIDS Behav       Date:  2018-08

5.  Willingness to initiate pre-exposure prophylaxis (PrEP) and its use among opioid-dependent individuals in drug treatment.

Authors:  Zhao Ni; Frederick L Altice; Jeffrey A Wickersham; Michael M Copenhaver; Elizabeth E DiDomizio; LaRon E Nelson; Roman Shrestha
Journal:  Drug Alcohol Depend       Date:  2021-01-07       Impact factor: 4.492

6.  Preferences for pre-exposure prophylaxis among U.S. military men who have sex with men: results of an adaptive choice based conjoint analysis study.

Authors:  José I Gutierrez; Alex Dubov; Frederick L Altice; David Vlahov
Journal:  Mil Med Res       Date:  2021-05-19

7.  Exploring the Use of Pre-exposure Prophylaxis (PrEP) for HIV Prevention Among High-Risk People Who Use Drugs in Treatment.

Authors:  Roman Shrestha; Michael Copenhaver
Journal:  Front Public Health       Date:  2018-07-13

8.  The Pre-exposure Prophylaxis (PrEP) Care Cascade in People Who Inject Drugs: A Systematic Review.

Authors:  Colleen B Mistler; Michael M Copenhaver; Roman Shrestha
Journal:  AIDS Behav       Date:  2021-05

9.  A Conjoint Analysis of the Acceptability of Targeted Long-Acting Injectable Antiretroviral Therapy Among Persons Living with HIV in the U.S.

Authors:  Jane M Simoni; Kenneth Tapia; Sung-Jae Lee; Susan M Graham; Kristin Beima-Sofie; Zahra H Mohamed; Joan Christodoulou; Rodney Ho; Ann C Collier
Journal:  AIDS Behav       Date:  2020-04

10.  Black Cisgender Women's PrEP Knowledge, Attitudes, Preferences, and Experience in Chicago.

Authors:  Lisa R Hirschhorn; Rayna N Brown; Eleanor E Friedman; George J Greene; Alvie Bender; Catherine Christeller; Alida Bouris; Amy K Johnson; Jim Pickett; Laxmi Modali; Jessica P Ridgway
Journal:  J Acquir Immune Defic Syndr       Date:  2020-08-15       Impact factor: 3.771

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.